speb/financial-data huggingface dataset:
PHO.OL income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 4971000.00
PHO.OL cash_flow (quarterly, 2025-06-30) — Interest Received Cfi: 3705000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Inventory: 38150000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Invested Capital: 479765000.00
PHO.OL cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 640000.00
PHO.OL cash_flow (quarterly, 2025-06-30) — Net Foreign Currency Exchange Gain Loss: 1202000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Net Income: 4864000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 4864000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 4864000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 4864000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 4864000.00
PHO.OL cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 2513000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 4864000.00
PHO.OL cash_flow (quarterly, 2025-06-30) — Net Intangibles Purchase And Sale: -1567000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Net Interest Income: -4943000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -4943000.00
PHO.OL cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -12549000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Net PPE: 16276000.00
PHO.OL cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1498000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 230949000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Assets: 49382000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 19735000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Normalized Income: 4864000.00
PHO.OL cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -6846000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Operating Income: 7456000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Operating Revenue: 135617000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 26606672.00
PHO.OL cash_flow (quarterly, 2025-06-30) — Other Cash Adjustment Outside Changein Cash: 2000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 57330000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Other Intangible Assets: 104816000.00
PHO.OL cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 2808000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 128051000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 32263000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Other Properties: 16276000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Other Receivables: 20515000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Payables: 20227000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Pretax Income: 2513000.00
PHO.OL cash_flow (quarterly, 2025-06-30) — Purchase Of Intangibles: -1567000.00
PHO.OL cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1498000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 10041000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 7308000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Research And Development: 506000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -18412000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 85351000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Selling General And Administration: 85351000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Share Issued: 27120820.00
PHO.OL cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 4384000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 479765000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 230949000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
PHO.OL income_statement (quarterly, 2025-06-30) — Tax Provision: -2351000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.22
PHO.OL balance_sheet (quarterly, 2025-06-30) — Total Assets: 685373000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 479765000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 479765000.00
PHO.OL income_statement (quarterly, 2025-06-30) — Total Expenses: 128161000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 205608000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 314474000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 128051000.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Treasury Shares Number: 514148.00
PHO.OL balance_sheet (quarterly, 2025-06-30) — Working Capital: 293343000.00
PHO.OL income_statement (annual, 2025-12-31) — +Operating Expense: 491330000.00
PHO.OL income_statement (quarterly, 2025-12-31) — +Operating Expense: 131257000.00
PHO.OL income_statement (annual, 2025-12-31) — +Total Revenue: 532580000.00
PHO.OL income_statement (quarterly, 2025-12-31) — +Total Revenue: 136668000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Accounts Payable: 29997000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 29997000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Accounts Receivable: 74919000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 74919000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -36774000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -36774000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 496081000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 496081000.00
PHO.OL income_statement (annual, 2025-12-31) — Basic Average Shares: 26661127.00
PHO.OL income_statement (quarterly, 2025-12-31) — Basic Average Shares: 26513333.00
PHO.OL income_statement (annual, 2025-12-31) — Basic EPS: -0.06
PHO.OL income_statement (quarterly, 2025-12-31) — Basic EPS: -0.30
PHO.OL cash_flow (annual, 2025-12-31) — Beginning Cash Position: 293852000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 247771000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 48931000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 48931000.00
PHO.OL cash_flow (annual, 2025-12-31) — Capital Expenditure: -21688000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -4198000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 10349000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 10349000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Capital Stock: 13560000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Capital Stock: 13560000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 234652000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 234652000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 234652000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 234652000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Cash Equivalents: 197214000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 197214000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Cash Financial: 37438000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Cash Financial: 37438000.00
PHO.OL cash_flow (annual, 2025-12-31) — Change In Inventory: -4837000.00
PHO.OL cash_flow (annual, 2025-12-31) — Change In Payable: 10372000.00
PHO.OL cash_flow (annual, 2025-12-31) — Change In Receivables: -11443000.00
PHO.OL cash_flow (annual, 2025-12-31) — Change In Working Capital: -8542000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -7895000.00
PHO.OL cash_flow (annual, 2025-12-31) — Changes In Cash: -54957000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Changes In Cash: -8878000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Common Stock: 13560000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Common Stock: 13560000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Common Stock Equity: 484231000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 484231000.00
PHO.OL cash_flow (annual, 2025-12-31) — Common Stock Payments: -29681000.00
PHO.OL income_statement (annual, 2025-12-31) — Cost Of Revenue: 41993000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 10926000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Current Assets: 385303000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Current Assets: 385303000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 5455000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 5455000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 5455000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 5455000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Current Liabilities: 110908000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 110908000.00
PHO.OL cash_flow (annual, 2025-12-31) — Depreciation: 29472000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Depreciation: 7431000.00
PHO.OL cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 29472000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 7431000.00
PHO.OL income_statement (annual, 2025-12-31) — Diluted Average Shares: 26661127.00
PHO.OL income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 26513333.00
PHO.OL income_statement (annual, 2025-12-31) — Diluted EPS: -0.06
PHO.OL income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.30
PHO.OL income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -1517000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -7954000.00
PHO.OL income_statement (annual, 2025-12-31) — EBIT: 7980000.00
PHO.OL income_statement (quarterly, 2025-12-31) — EBIT: -2264000.00
PHO.OL income_statement (annual, 2025-12-31) — EBITDA: 37452000.00
PHO.OL income_statement (quarterly, 2025-12-31) — EBITDA: 5167000.00
PHO.OL cash_flow (annual, 2025-12-31) — End Cash Position: 238894000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — End Cash Position: 238894000.00
PHO.OL cash_flow (annual, 2025-12-31) — Financing Cash Flow: -77167000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -7112000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Finished Goods: 6000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Finished Goods: 6000.00
PHO.OL cash_flow (annual, 2025-12-31) — Free Cash Flow: 9980000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -4671000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Goodwill: 144000000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Goodwill: 144000000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 251968000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 251968000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Gross PPE: 50199000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Gross PPE: 50199000.00
PHO.OL income_statement (annual, 2025-12-31) — Gross Profit: 490587000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Gross Profit: 125742000.00
PHO.OL income_statement (annual, 2025-12-31) — Interest Expense: 24670000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Interest Expense: 7156000.00
PHO.OL income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 24670000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 7156000.00
PHO.OL income_statement (annual, 2025-12-31) — Interest Income: 12233000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Interest Income: 3249000.00
PHO.OL income_statement (annual, 2025-12-31) — Interest Income Non Operating: 12233000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 3249000.00
PHO.OL cash_flow (annual, 2025-12-31) — Interest Paid Cff: -673000.00
PHO.OL cash_flow (annual, 2025-12-31) — Interest Received Cfi: 12230000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Interest Received Cfi: 2905000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Inventory: 44374000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Inventory: 44374000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Invested Capital: 484231000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Invested Capital: 484231000.00
PHO.OL cash_flow (annual, 2025-12-31) — Investing Cash Flow: -9458000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -1293000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Investmentsin Subsidiariesat Cost: 0.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Investmentsin Subsidiariesat Cost: 0.00
PHO.OL balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 4894000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 4894000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4894000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 4894000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 0.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 0.00
PHO.OL balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 1268000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 1268000.00
PHO.OL cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -29681000.00
PHO.OL cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 128000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 688000.00
PHO.OL income_statement (annual, 2025-12-31) — Net Income: -1517000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Net Income: -7954000.00
PHO.OL income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -1517000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -7954000.00
PHO.OL income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -1517000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -7954000.00
PHO.OL income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1517000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -7954000.00
PHO.OL income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1517000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -7954000.00
PHO.OL cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -16690000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -9420000.00
PHO.OL income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -1517000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -7954000.00
PHO.OL cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -20131000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -4124000.00
PHO.OL income_statement (annual, 2025-12-31) — Net Interest Income: -12677000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Net Interest Income: -3907000.00
PHO.OL income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -12677000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -3907000.00
PHO.OL cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -53045000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -5836000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Net PPE: 13425000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Net PPE: 13425000.00
PHO.OL cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -21688000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -74000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 232263000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 232263000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 55874000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 55874000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 6454000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 6454000.00
PHO.OL income_statement (annual, 2025-12-31) — Normalized EBITDA: 37452000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 5167000.00
PHO.OL income_statement (annual, 2025-12-31) — Normalized Income: -1517000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Normalized Income: -7954000.00
PHO.OL cash_flow (annual, 2025-12-31) — Operating Cash Flow: 31668000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -473000.00
PHO.OL income_statement (annual, 2025-12-31) — Operating Income: -743000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Operating Income: -5515000.00
PHO.OL income_statement (annual, 2025-12-31) — Operating Revenue: 532580000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Operating Revenue: 136668000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 26606672.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 26606672.00
PHO.OL cash_flow (annual, 2025-12-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 1000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 1000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 107968000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 107968000.00
PHO.OL cash_flow (annual, 2025-12-31) — Other Non Cash Items: 9411000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 2994000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 100083000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 100083000.00
PHO.OL income_statement (annual, 2025-12-31) — Other Operating Expenses: 127229000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 32278000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Other Properties: 13425000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Other Properties: 13425000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Other Receivables: 7678000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Other Receivables: 7678000.00
PHO.OL income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
PHO.OL income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
PHO.OL balance_sheet (annual, 2025-12-31) — Payables: 32408000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Payables: 32408000.00
PHO.OL cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: 732000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Prepaid Assets: 19438000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 19438000.00
PHO.OL income_statement (annual, 2025-12-31) — Pretax Income: -16690000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Pretax Income: -9420000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Properties: 0.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
PHO.OL cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -20131000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -4124000.00
PHO.OL cash_flow (annual, 2025-12-31) — Purchase Of PPE: -21688000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -74000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Raw Materials: 4216000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Raw Materials: 4216000.00
PHO.OL income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 41993000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 10926000.00
PHO.OL income_statement (annual, 2025-12-31) — Reconciled Depreciation: 29472000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 7431000.00
PHO.OL cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -29681000.00
PHO.OL income_statement (annual, 2025-12-31) — Research And Development: 402000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Research And Development: -414000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Restricted Cash: 4242000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 4242000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Retained Earnings: -25410000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -25410000.00
PHO.OL income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 363699000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 99393000.00
PHO.OL income_statement (annual, 2025-12-31) — Selling General And Administration: 363699000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Selling General And Administration: 99393000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Share Issued: 27120820.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Share Issued: 27120820.00
PHO.OL cash_flow (annual, 2025-12-31) — Stock Based Compensation: 18789000.00
PHO.OL cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 4759000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Stockholders Equity: 484231000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 484231000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Tangible Book Value: 232263000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 232263000.00
PHO.OL income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
PHO.OL income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
PHO.OL income_statement (annual, 2025-12-31) — Tax Provision: -15173000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Tax Provision: -1466000.00
PHO.OL income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.22
PHO.OL income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.16
PHO.OL cash_flow (annual, 2025-12-31) — Taxes Refund Paid: -1631000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Total Assets: 706570000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Total Assets: 706570000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Total Capitalization: 484231000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 484231000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Total Debt: 10349000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Total Debt: 10349000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 484231000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 484231000.00
PHO.OL income_statement (annual, 2025-12-31) — Total Expenses: 533323000.00
PHO.OL income_statement (quarterly, 2025-12-31) — Total Expenses: 142183000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 222339000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 222339000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 321267000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 321267000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 111431000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 111431000.00
PHO.OL income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -743000.00
PHO.OL income_statement (annual, 2025-12-31) — Total Other Finance Cost: 240000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Total Tax Payable: 2411000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 2411000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 514148.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 514148.00
PHO.OL balance_sheet (annual, 2025-12-31) — Work In Process: 40152000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Work In Process: 40152000.00
PHO.OL balance_sheet (annual, 2025-12-31) — Working Capital: 274395000.00
PHO.OL balance_sheet (quarterly, 2025-12-31) — Working Capital: 274395000.00
PHO.OL income_statement (quarterly, 2026-03-31) — +Operating Expense: 133577000.00
PHO.OL income_statement (quarterly, 2026-03-31) — +Total Revenue: 264607000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 17745000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 203620000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 499547000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Basic Average Shares: 26606672.00
PHO.OL income_statement (quarterly, 2026-03-31) — Basic EPS: 3.14
PHO.OL cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 238894000.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -7413000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Capital Stock: 13560000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 192691000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 192691000.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -130731000.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Changes In Cash: -46204000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Common Stock: 13560000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 577911000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 10349000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Current Assets: 460422000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 96044000.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Depreciation: 7634000.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 7634000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 26771558.00
PHO.OL income_statement (quarterly, 2026-03-31) — Diluted EPS: 3.12
PHO.OL income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 83419000.00
PHO.OL income_statement (quarterly, 2026-03-31) — EBIT: 130091000.00
PHO.OL income_statement (quarterly, 2026-03-31) — EBITDA: 137725000.00
PHO.OL cash_flow (quarterly, 2026-03-31) — End Cash Position: 192691000.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -12580000.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -6639000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Goodwill: 144000000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 253156000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Gross PPE: 13665000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Gross Profit: 254258000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Interest Expense: 20673000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 20673000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Interest Income: 9409000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 9409000.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Interest Received Cfi: 1715000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Inventory: 39435000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Invested Capital: 577911000.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -34398000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Investments In Other Ventures Under Equity Method: 28700000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 28700000.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 11115000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Net Income: 83419000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 83419000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 83419000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 83419000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 83419000.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 109418000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 83419000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Net Interest Income: -11264000.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -28700000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -11264000.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -10113000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Net PPE: 13665000.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -7413000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 324755000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 30088000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 137725000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Normalized Income: 83419000.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 774000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Operating Income: 120681000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Operating Revenue: 264607000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 26606672.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Other Current Assets: -1000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 78299000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 109156000.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 3606000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: -1000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 112075000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 38238000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Other Properties: 13665000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Other Receivables: 24677000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Payables: 17745000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Pretax Income: 109418000.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -7413000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 10349000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 7634000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Research And Development: 529000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 64804000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 94810000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Selling General And Administration: 94810000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Share Issued: 27120820.00
PHO.OL cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 4329000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 577911000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 324755000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
PHO.OL income_statement (quarterly, 2026-03-31) — Tax Provision: 25999000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.24
PHO.OL balance_sheet (quarterly, 2026-03-31) — Total Assets: 786030000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 577911000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 577911000.00
PHO.OL income_statement (quarterly, 2026-03-31) — Total Expenses: 143926000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 208119000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 325608000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 112075000.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 514148.00
PHO.OL balance_sheet (quarterly, 2026-03-31) — Working Capital: 364378000.00
PHOE income_statement (annual, 2023-03-31) — +Operating Expense: 188481.00
PHOE income_statement (annual, 2023-03-31) — +Total Revenue: 2228484.00
PHOE balance_sheet (annual, 2023-03-31) — Accounts Payable: 348645.00
PHOE balance_sheet (annual, 2023-03-31) — Accounts Receivable: 997134.00
PHOE balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -104966.00
PHOE balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 3.00
PHOE balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -10933.00
PHOE income_statement (annual, 2023-03-31) — Basic Average Shares: 21600000.00
PHOE income_statement (annual, 2023-03-31) — Basic EPS: 0.02
PHOE cash_flow (annual, 2023-03-31) — Beginning Cash Position: 466110.00
PHOE cash_flow (annual, 2023-03-31) — Capital Expenditure: -22607.00
PHOE balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 71240.00
PHOE balance_sheet (annual, 2023-03-31) — Capital Stock: 161.00
PHOE balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 377746.00
PHOE balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 377746.00
PHOE balance_sheet (annual, 2023-03-31) — Cash Financial: 377746.00
PHOE cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Financing Activities: -8645.00
PHOE cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Investing Activities: -22607.00
PHOE cash_flow (annual, 2023-03-31) — Cash Flow From Continuing Operating Activities: -57112.00
PHOE cash_flow (annual, 2023-03-31) — Change In Account Payable: -120100.00
PHOE cash_flow (annual, 2023-03-31) — Change In Accrued Expense: -30495.00
PHOE cash_flow (annual, 2023-03-31) — Change In Income Tax Payable: 7107.00
PHOE cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -24080.00
PHOE cash_flow (annual, 2023-03-31) — Change In Other Working Capital: 34766.00
PHOE cash_flow (annual, 2023-03-31) — Change In Payable: -299066.00
PHOE cash_flow (annual, 2023-03-31) — Change In Payables And Accrued Expense: -329561.00
PHOE cash_flow (annual, 2023-03-31) — Change In Prepaid Assets: -1282.00
PHOE cash_flow (annual, 2023-03-31) — Change In Receivables: -108855.00
PHOE cash_flow (annual, 2023-03-31) — Change In Tax Payable: 7107.00
PHOE cash_flow (annual, 2023-03-31) — Change In Working Capital: -429012.00
PHOE cash_flow (annual, 2023-03-31) — Changes In Account Receivables: -163389.00
PHOE cash_flow (annual, 2023-03-31) — Changes In Cash: -88364.00
PHOE balance_sheet (annual, 2023-03-31) — Common Stock: 161.00
PHOE balance_sheet (annual, 2023-03-31) — Common Stock Equity: 651964.00
PHOE cash_flow (annual, 2023-03-31) — Common Stock Issuance: 0.00
PHOE income_statement (annual, 2023-03-31) — Cost Of Revenue: 1663220.00
PHOE balance_sheet (annual, 2023-03-31) — Current Accrued Expenses: 12147.00
PHOE balance_sheet (annual, 2023-03-31) — Current Assets: 1391098.00
PHOE balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 31002.00
PHOE balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 31002.00
PHOE balance_sheet (annual, 2023-03-31) — Current Deferred Liabilities: 34766.00
PHOE balance_sheet (annual, 2023-03-31) — Current Deferred Revenue: 34766.00
PHOE balance_sheet (annual, 2023-03-31) — Current Liabilities: 852864.00
PHOE cash_flow (annual, 2023-03-31) — Deferred Income Tax: 33653.00
PHOE cash_flow (annual, 2023-03-31) — Deferred Tax: 33653.00
PHOE cash_flow (annual, 2023-03-31) — Depreciation: 43862.00
PHOE cash_flow (annual, 2023-03-31) — Depreciation Amortization Depletion: 43862.00
PHOE cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 43862.00
PHOE income_statement (annual, 2023-03-31) — Diluted Average Shares: 21600000.00
PHOE income_statement (annual, 2023-03-31) — Diluted EPS: 0.02
PHOE income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 351065.00
PHOE balance_sheet (annual, 2023-03-31) — Dueto Related Parties Current: 394826.00
PHOE income_statement (annual, 2023-03-31) — EBIT: 392963.00
PHOE income_statement (annual, 2023-03-31) — EBITDA: 436825.00
PHOE balance_sheet (annual, 2023-03-31) — Employee Benefits: 6965.00
PHOE cash_flow (annual, 2023-03-31) — End Cash Position: 377746.00
PHOE cash_flow (annual, 2023-03-31) — Financing Cash Flow: -8645.00
PHOE cash_flow (annual, 2023-03-31) — Free Cash Flow: -79719.00
PHOE cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -2564.00
PHOE income_statement (annual, 2023-03-31) — General And Administrative Expense: 188481.00
PHOE balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 1008067.00
PHOE balance_sheet (annual, 2023-03-31) — Gross PPE: 201164.00
PHOE income_statement (annual, 2023-03-31) — Gross Profit: 565264.00
PHOE cash_flow (annual, 2023-03-31) — Income Tax Paid Supplemental Data: 0.00
PHOE balance_sheet (annual, 2023-03-31) — Income Tax Payable: 24848.00
PHOE income_statement (annual, 2023-03-31) — Interest Expense: 1137.00
PHOE income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 1137.00
PHOE cash_flow (annual, 2023-03-31) — Interest Paid Supplemental Data: 1137.00
PHOE balance_sheet (annual, 2023-03-31) — Invested Capital: 651964.00
PHOE cash_flow (annual, 2023-03-31) — Investing Cash Flow: -22607.00
PHOE cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 0.00
PHOE balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 40238.00
PHOE balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 40238.00
PHOE cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -8645.00
PHOE balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 121781.00
PHOE cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 0.00
PHOE income_statement (annual, 2023-03-31) — Net Income: 351065.00
PHOE income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 351065.00
PHOE income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 351065.00
PHOE income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 351065.00
PHOE income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 351065.00
PHOE cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 351065.00
PHOE income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 351065.00
PHOE income_statement (annual, 2023-03-31) — Net Interest Income: -1137.00
PHOE cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -8645.00
PHOE cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -8645.00
PHOE income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -1137.00
PHOE balance_sheet (annual, 2023-03-31) — Net PPE: 96198.00
PHOE cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -22607.00
PHOE balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 651964.00
PHOE balance_sheet (annual, 2023-03-31) — Non Current Accounts Receivable: 110771.00
PHOE balance_sheet (annual, 2023-03-31) — Non Current Deferred Assets: 0.00
PHOE balance_sheet (annual, 2023-03-31) — Non Current Deferred Liabilities: 46036.00
PHOE balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 0.00
PHOE balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 46036.00
PHOE balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 6965.00
PHOE income_statement (annual, 2023-03-31) — Normalized EBITDA: 436825.00
PHOE income_statement (annual, 2023-03-31) — Normalized Income: 351065.00
PHOE cash_flow (annual, 2023-03-31) — Operating Cash Flow: -57112.00
PHOE cash_flow (annual, 2023-03-31) — Operating Gains Losses: 4401.00
PHOE income_statement (annual, 2023-03-31) — Operating Income: 376783.00
PHOE income_statement (annual, 2023-03-31) — Operating Revenue: 2228484.00
PHOE balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 21600000.00
PHOE balance_sheet (annual, 2023-03-31) — Other Equity Interest: -161.00
PHOE income_statement (annual, 2023-03-31) — Other Gand A: 188481.00
PHOE income_statement (annual, 2023-03-31) — Other Income Expense: 16180.00
PHOE income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 16180.00
PHOE balance_sheet (annual, 2023-03-31) — Other Properties: 79383.00
PHOE balance_sheet (annual, 2023-03-31) — Other Receivables: 9564.00
PHOE balance_sheet (annual, 2023-03-31) — Payables: 768319.00
PHOE balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 780466.00
PHOE cash_flow (annual, 2023-03-31) — Pension And Employee Benefit Expense: 6965.00
PHOE balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 6630.00
PHOE balance_sheet (annual, 2023-03-31) — Prepaid Assets: 6654.00
PHOE income_statement (annual, 2023-03-31) — Pretax Income: 391826.00
PHOE cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: -61081.00
PHOE cash_flow (annual, 2023-03-31) — Purchase Of PPE: -22607.00
PHOE balance_sheet (annual, 2023-03-31) — Receivables: 1006698.00
PHOE income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 1663220.00
PHOE income_statement (annual, 2023-03-31) — Reconciled Depreciation: 43862.00
PHOE cash_flow (annual, 2023-03-31) — Repayment Of Debt: -8645.00
PHOE balance_sheet (annual, 2023-03-31) — Retained Earnings: 651961.00
PHOE cash_flow (annual, 2023-03-31) — Sale Of PPE: 0.00
PHOE income_statement (annual, 2023-03-31) — Selling General And Administration: 188481.00
PHOE balance_sheet (annual, 2023-03-31) — Share Issued: 21600000.00
PHOE balance_sheet (annual, 2023-03-31) — Stockholders Equity: 651964.00
PHOE balance_sheet (annual, 2023-03-31) — Tangible Book Value: 651964.00
PHOE income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 0.00
PHOE income_statement (annual, 2023-03-31) — Tax Provision: 40761.00
PHOE income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.10
PHOE balance_sheet (annual, 2023-03-31) — Total Assets: 1598067.00
PHOE balance_sheet (annual, 2023-03-31) — Total Capitalization: 651964.00
PHOE balance_sheet (annual, 2023-03-31) — Total Debt: 71240.00
PHOE balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 651964.00
PHOE income_statement (annual, 2023-03-31) — Total Expenses: 1851701.00
PHOE balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 946103.00
PHOE balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 206969.00
PHOE balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 93239.00
PHOE income_statement (annual, 2023-03-31) — Total Operating Income As Reported: 376783.00
PHOE balance_sheet (annual, 2023-03-31) — Total Tax Payable: 24848.00
PHOE balance_sheet (annual, 2023-03-31) — Working Capital: 538234.00
PHOE income_statement (annual, 2024-03-31) — +Operating Expense: 251493.00
PHOE income_statement (annual, 2024-03-31) — +Total Revenue: 5755641.00
PHOE balance_sheet (annual, 2024-03-31) — Accounts Payable: 1472935.00
PHOE balance_sheet (annual, 2024-03-31) — Accounts Receivable: 2489147.00
PHOE balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -110958.00
PHOE balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 3.00
PHOE balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -10248.00
PHOE income_statement (annual, 2024-03-31) — Basic Average Shares: 21600000.00
PHOE income_statement (annual, 2024-03-31) — Basic EPS: 0.05
PHOE cash_flow (annual, 2024-03-31) — Beginning Cash Position: 377746.00
PHOE balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 51174.00
PHOE balance_sheet (annual, 2024-03-31) — Capital Stock: 161.00
PHOE balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 890578.00
PHOE balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 890578.00
PHOE balance_sheet (annual, 2024-03-31) — Cash Financial: 890578.00
PHOE cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: -33910.00
PHOE cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: 6410.00
PHOE cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Operating Activities: 540332.00
PHOE cash_flow (annual, 2024-03-31) — Change In Account Payable: 1124290.00
PHOE cash_flow (annual, 2024-03-31) — Change In Accrued Expense: 62324.00
PHOE cash_flow (annual, 2024-03-31) — Change In Income Tax Payable: 197581.00
PHOE cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: -11796.00
PHOE cash_flow (annual, 2024-03-31) — Change In Other Working Capital: -34766.00
PHOE cash_flow (annual, 2024-03-31) — Change In Payable: 1091102.00
PHOE cash_flow (annual, 2024-03-31) — Change In Payables And Accrued Expense: 1153426.00
PHOE cash_flow (annual, 2024-03-31) — Change In Prepaid Assets: 1282.00
PHOE cash_flow (annual, 2024-03-31) — Change In Receivables: -1613662.00
PHOE cash_flow (annual, 2024-03-31) — Change In Tax Payable: 197581.00
PHOE cash_flow (annual, 2024-03-31) — Change In Working Capital: -505516.00
PHOE cash_flow (annual, 2024-03-31) — Changes In Account Receivables: -1491327.00
PHOE cash_flow (annual, 2024-03-31) — Changes In Cash: 512832.00
PHOE balance_sheet (annual, 2024-03-31) — Common Stock: 161.00
PHOE balance_sheet (annual, 2024-03-31) — Common Stock Equity: 1708547.00
PHOE cash_flow (annual, 2024-03-31) — Common Stock Issuance: 0.00
PHOE income_statement (annual, 2024-03-31) — Cost Of Revenue: 4271468.00
PHOE balance_sheet (annual, 2024-03-31) — Current Accrued Expenses: 13184.00
PHOE balance_sheet (annual, 2024-03-31) — Current Assets: 3464682.00
PHOE balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 26565.00
PHOE balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 26565.00
PHOE balance_sheet (annual, 2024-03-31) — Current Deferred Assets: 0.00
PHOE balance_sheet (annual, 2024-03-31) — Current Deferred Liabilities: 0.00
PHOE balance_sheet (annual, 2024-03-31) — Current Deferred Revenue: 0.00
PHOE balance_sheet (annual, 2024-03-31) — Current Liabilities: 1967087.00
PHOE cash_flow (annual, 2024-03-31) — Deferred Income Tax: -47237.00
PHOE cash_flow (annual, 2024-03-31) — Deferred Tax: -47237.00
PHOE cash_flow (annual, 2024-03-31) — Depreciation: 40717.00
PHOE cash_flow (annual, 2024-03-31) — Depreciation Amortization Depletion: 40717.00
PHOE cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 40717.00
PHOE income_statement (annual, 2024-03-31) — Diluted Average Shares: 21600000.00
PHOE income_statement (annual, 2024-03-31) — Diluted EPS: 0.05
PHOE income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 1056583.00
PHOE balance_sheet (annual, 2024-03-31) — Dueto Related Parties Current: 164057.00
PHOE income_statement (annual, 2024-03-31) — EBIT: 1240470.00